In a retrospective analysis, serum SDF-1α levels were significantly higher in elderly patients with AML (n = 187) compared to age-matched control subjects (n = 120, p< 0.001, Figure 1A). This evidence concerns the gene CXCL12 and acute myeloid leukemia.